526
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Insulin-like growth factor-1 (IGF-1) poly (lactic-co-glycolic acid) (PLGA) microparticles – development, characterisation, and in vitro assessment of bioactivity for cardiac applications

ORCID Icon, , , , , & show all
Pages 267-277 | Received 10 Oct 2018, Accepted 20 May 2019, Published online: 14 Jun 2019
 

Abstract

Aim: The aim of this study was to evaluate the formulation of a synthetic IGF-1 (pIGF-1) in PLGA microparticles (MP).

Methods: Poly (lactic-co-glycolic acid) (PLGA) MPs loaded with pIGF-1 were prepared, characterised and evaluated using double emulsion solvent evaporation method.

Results: Spherical MPs showed an average particle size of 2 µm, encapsulation efficiency (EE) of 67% and 50% degradation over 15 days. With a view to enhancing retention in the myocardium, the MP formulation was encapsulated in a cross-linked hyaluronic acid hydrogel. pIGF-1 released from MPs and from MPs suspended in hyaluronic acid hydrogel remained bioactive, determined by a significant increase in cellular proliferation of c-kit+ cells.

Conclusion: This formulation has potential for loco-regional delivery to damaged myocardium to promote the survival of cardiomyocytes.

Acknowledgments

Synthetic IGF-1 (pIGF-1) was sourced from Pepscan, Zuidersluisweg 2, 8243 RC Lelystad, Netherlands (supplied through our collaborator Celyad, Mont-Saint-Guibert, Belgium).

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study was part of the AMCARE (Advanced Materials for Cardiac Regeneration) project that has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 604531.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.